Vedic medicine, and a study in Nepal provides an insightful look into how O. sinensis is used to create end products. Surprisingly, only a small number of industries, just four in the entire country, are actively involved in the processing of O. sinensis to produce these end products. The study found that these industries manufacture four main types of products: Ayurvedic tonics, dietary supplements, alcoholic beverages, and sex stimulant tea. These end products are marketed for a range of health benefits, including enhancing immunity, boosting stamina, inducing relaxation, increasing energy levels, and aiding in the treatment of various health disorders. Despite these diverse applications, the domestic industrial consumption of O. sinensis in Nepal is surprisingly low. In 2015/2016, these four industries processed only 10 kg of the fungus which is negligible compared to the amount harvested. This indicates that the majority of the harvested O. sinensis is traded in its raw form, with significant amounts being exported to China. The high value of the raw fungus combined with its suitability for direct consumption might be the reason for the low processing levels in Nepal. Comparatively, there are 23 industries in Nepal that process Neopicrorhiza scrophulariiflora, highlighting the infancy of the processing industry of O. sinensis. This presents a substantial opportunity for Nepal to expand its domestic herbal processing industries, particularly for highly valued medicinal plants. The diversification of end products derived from O. sinensis could stimulate the national economy, as well as improve public health by making these products more accessible. The existing Industrial Policy of Nepal, which recognizes the importance of Ayurvedic and homeopathic medicine manufacturing, indicates that there is room for expansion in this sector, and future policy should ensure the sustainable harvesting and processing of this valuable resource, benefiting both the local communities and the national economy.